Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).
about
Cytokines as new treatment targets in chronic heart failureMyocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesisCardiovascular comorbidity in rheumatic diseases: a focus on heart failureCardiac biomarkers: new tools for heart failure managementAssociation of Hepatitis C Virus Seropositivity With Inflammatory Markers and Heart Failure in Persons With Coronary Heart Disease: Data From the Heart and Soul StudyHeme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagyCardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandinsEnhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failureChronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathyPrognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trialsGhrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?A comparison of risk factors for mortality from heart failure in Asian and non-Asian populations: an overview of individual participant data from 32 prospective cohorts from the Asia-Pacific Region.Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis.Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities.Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock.Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis.Salt intake is associated with inflammation in chronic heart failure.Symbolic analysis detects alterations of cardiac autonomic modulation in congestive heart failure ratsLycopene dietary intervention: a pilot study in patients with heart failureThe relationship between red blood cell distribution width and blood pressure in patients with type 2 diabetes mellitus in Lagos, Nigeria.A heart that beats for 500 years: age-related changes in cardiac proteasome activity, oxidative protein damage and expression of heat shock proteins, inflammatory factors, and mitochondrial complexes in Arctica islandica, the longest-living noncolonLow-level laser therapy improves the inflammatory profile of rats with heart failure.The importance of the gastrointestinal system in the pathogenesis of heart failure.Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure.Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study.Effect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failureChronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular diseaseLipopolysaccharide and cytokines inhibit rat cardiomyocyte contractility in vitroDissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients.Changes in Glucose, TNF-α and IL-6 Blood Levels in Middle-aged Women Associated with Aerobic Exercise and Meditation TrainingThe MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fractionCellular remodeling in heart failure disrupts K(ATP) channel-dependent stress toleranceClinical and serum-based markers are associated with death within 1 year of de novo implant in primary prevention ICD recipients.Targeting inflammation in heart failure with histone deacetylase inhibitors.Biomarkers of myocardial stress and systemic inflammation in patients who engage in heart failure self-care management.Heart failure and the brain: new perspectives.Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan diastolic heart failure registry and molecular basis by cellular and animal models.
P2860
Q24799394-08DD5FCE-20F2-429E-96C2-6A6E838EB6F8Q24812557-5554E1AA-5EC0-4CCD-85A9-DE774956FEB3Q26823443-952FB397-D9FD-45B6-90FB-255F94B09F79Q26991726-1872614B-EC7A-47F9-B0FB-FDB268E517CAQ27490429-BAB353F3-B5FB-4ACC-84B7-4D6A9F1BD09DQ28533775-C994EDD6-DC08-4CD9-A8ED-4283B8155BD5Q28581223-34B9FEED-EFC1-4357-B16B-8879D9D1B5F2Q28731260-A8D91FC7-F4A9-4EE9-B292-1025D214A5B8Q28742889-3BBF6E06-E3C2-4392-B690-F966EEF99950Q30413291-537C3753-B2B7-46D1-A625-59D0F5965308Q30426403-BA3DC0E2-F8F6-4A88-B180-12594B972CCFQ30828094-D2222960-7108-47E9-86CB-8CD771134FBBQ30886019-B6803AA1-0E68-481D-9B65-A414D107D597Q33421711-833F4FB3-6D83-4410-8924-252E74F2D0B9Q33488545-0C2C87FF-930C-45D0-A635-DE8AE24CAE7BQ33751148-39BA2E25-24E4-41E1-8DBF-1E64E80614B9Q33764598-FFCBF474-902B-43F2-BAE7-1E6F99FD48D2Q33942433-1DB8B38D-4C81-45AA-AEAA-4F750944C459Q34097170-252836B9-B109-4C54-A0AF-2C30AB297F8AQ34207466-DAA2CDFD-3B8B-4869-B2E0-F96333396926Q34265524-1D33DECC-3EB6-4304-A705-A1604E43907BQ34392563-BB7585B3-E22A-4A5C-A44E-E64E8556EC3AQ34398672-2742BECB-AF56-43AB-99AB-9325A710200CQ34429097-A8EB98A3-4AE3-4BE7-BBBA-0E1D915FA25BQ34498176-FB9A0539-917F-4741-8C27-7A3FB4C3B5EEQ34609134-89B60A21-F2D5-49B8-BA14-38D888DAA0D2Q34635227-E3D38FDC-DDDA-4708-A2CD-DF8B5DD1590BQ34684222-312986EF-A060-402B-9B77-FE57E7F1924AQ34684331-59B52A7B-0D04-4FFB-A829-4774AA0E00DDQ34718320-9F22F81E-80EB-4589-8A83-EFD1CA754614Q34722642-5D777EFD-5E09-4BB8-93A5-CF4E7B1A2DE2Q34750239-8A428B42-2D4C-48D3-9616-5BA743258C88Q34793636-81B82E50-ACC4-495F-B95B-42415746CB3EQ34873552-4B064232-31FA-4778-B566-EC0E62AE29C3Q34986013-2643A700-21BA-4AFA-841A-0B7CF0C2CD99Q35001908-96B3F46F-D254-4AE6-9C26-7FEFF9E43FDCQ35016989-A6D43CCD-7E0C-42CD-9FDD-833159C3442EQ35043024-7E835486-1DBE-4E7E-9E58-604A1628472AQ35046024-A855EB60-C9F3-45A6-A8B5-4C20E2C48F69Q35086172-B55DD622-7782-4454-A544-FD16EE4DFCDC
P2860
Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Cytokines and cytokine recepto ...... the Vesnarinone trial (VEST).
@en
Cytokines and cytokine recepto ...... ase from the Vesnarinone trial
@nl
type
label
Cytokines and cytokine recepto ...... the Vesnarinone trial (VEST).
@en
Cytokines and cytokine recepto ...... ase from the Vesnarinone trial
@nl
prefLabel
Cytokines and cytokine recepto ...... the Vesnarinone trial (VEST).
@en
Cytokines and cytokine recepto ...... ase from the Vesnarinone trial
@nl
P2093
P1433
P1476
Cytokines and cytokine recepto ...... the Vesnarinone trial (VEST).
@en
P2093
P304
P356
10.1161/01.CIR.103.16.2055
P407
P577
2001-04-01T00:00:00Z